Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: MRNA

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Earnings
  • Eurozone
  • Futures
  • Global
  • Markets
  • News
  • Pre-Market Outlook
  • Small Cap

A Peek Into The Markets: US Stock Futures Gain Ahead Of Manufacturing Data

By Lisa Levin
August 2, 6:09 AM
Pre-open movers

EMN

Read More
2 minute read
  • Biotech
  • Media
  • News

Pfizer, Moderna Hike Prices Of Vaccine Shots Supplied To EU: Report

By Shanthi Rexaline
August 1, 4:34 PM
Pfizer, Inc. (NYSE: PFE) and Moderna, Inc. (NASDAQ: MRNA), which have already minted billions of dollars from their respective COVID-19 vaccines, remain poised to earn more.

AZN

Read More
1 minute read
  • Eurozone
  • Markets
  • News

Pfizer, Moderna Raise EU COVID Vaccine Prices

By Charles Gross
August 1, 12:01 PM
-FT https://www.ft.com/content/d415a01e-d065-44a9-bad4-f9235aa04c1a

BNTX

Read More
2 minute read
  • Markets
  • Options

Unusual Options Activity Insight: Moderna

By Benzinga Insights
July 29, 2:14 PM
Moderna (NASDAQ:MRNA) shares experienced unusual options activity on Thursday. The stock price moved down to $340.01 following the option alert.

MRNA

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Cashing COVID-19 Vaccine – AstraZeneca Or Pfizer

By Vandana Singh
July 29, 1:47 PM
Today AstraZeneca plc (NASDAQ: AZN) released its second-quarter earnings with updated sales numbers for its COVID-19 vaccine; when compared to the big mRNA players, the numbers looked rather pale.

AZN

Read More
1 minute read
  • Trading Ideas

Top 20 Trending Stocks On WallStreetBets As Of Thursday, July 29, 2021 (Via Swaggy Stocks)

By Michael Horton
July 29, 9:38 AM
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment Tilray (TLRY) Advanced Micro Devices (AMD) Facebook (FB) GameStop (GME) Apple (AAPL) Cleveland-Cliffs (CLF) ContextLogic

AAPL

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • News

FDA Asks Pfizer/BioNTech, Moderna To Expand COVID-19 Vaccine Trials In Children: NYT

By Vandana Singh
July 26, 1:53 PM
Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) will expand the size of o

BNTX

Read More
1 minute read
  • FDA
  • General
  • News
  • Politics

White House Says U.S. Seeing A Significant Rise In COVID-19 Vases Among Unvaccinated Americans; Says ‘We Are Seeing That Across The Country’

By Benzinga Newsdesk
July 26, 1:08 PM
-Reuters

APT

Read More
1 minute read
  • General
  • Media
  • News
  • Politics
  • Rumors

UPDATE: ‘At the F.D.A.’s urging, Pfizer-BioNTech and Moderna are expanding their vaccine studies of children under 11.’ -NY Times $

By Benzinga Newsdesk
July 26, 12:39 PM
https://www.nytimes.com/2021/07/26/us/politics/fda-covid-vaccine-trials-children.html?action=click&module=Spotlight&pgtype=Homepage

BNTX

Read More
1 minute read
  • FDA
  • News

Pfizer, Moderna Expand Vaccine Studies Of Children Under 11

By Benzinga Newsdesk
July 26, 12:37 PM
-New York Times

BNTX

Posts navigation

Previous 1 … 116 117 118 … 136 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service